Barclays
HIMS icon

Barclays’s Hims & Hers Health HIMS Stock Holding History

Barclays’s Portfolio HIMS Stock Details HIMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$29.9M Buy
861,006
+221,634
+35% +$5.95M 0.01% 933
2026
Q1 		$13.3M Sell
639,372
-314,099
-33% -$7.42M ﹤0.01% 1307
2025
Q4 		$31M Buy
953,471
+294,500
+45% +$12.6M 0.01% 1008
2025
Q3 		$37.4M Buy
658,971
+44,292
+7% +$2.27M 0.01% 905
2025
Q2 		$30.6M Buy
614,679
+261,314
+74% +$11.8M 0.01% 916
2025
Q1 		$10.4M Sell
353,365
-103,881
-23% -$3.86M ﹤0.01% 1372
2024
Q4 		$11.1M Buy
457,246
+148,883
+48% +$3.69M ﹤0.01% 1502
2024
Q3 		$5.68M Buy
308,363
+27,231
+10% +$488K ﹤0.01% 1980
2024
Q2 		$5.68M Buy
281,132
+128,223
+84% +$2.13M ﹤0.01% 1463
2024
Q1 		$2.37M Sell
152,909
-181,918
-54% -$2.05M ﹤0.01% 2432
2023
Q4 		$2.98M Buy
334,827
+23,506
+8% +$174K ﹤0.01% 2564
2023
Q3 		$1.96M Sell
311,321
-274,939
-47% -$2.04M ﹤0.01% 1916
2023
Q2 		$5.51M Buy
586,260
+302,334
+106% +$3M ﹤0.01% 1292
2023
Q1 		$2.82M Buy
283,926
+251,338
+771% +$2.2M ﹤0.01% 1939
2022
Q4 		$209K Buy
32,588
+27,442
+533% +$156K ﹤0.01% 3815
2022
Q3 		$29K Sell
5,146
-946
-16% -$5.7K ﹤0.01% 3949
2022
Q2 		$28K Buy
6,092
+5,731
+1,588% +$24.4K ﹤0.01% 4269
2022
Q1 		$2K Buy
+361
New +$1.79K ﹤0.01% 4784

Other funds holding HIMS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
DSCM
Divisadero Street Capital Management Miami, Florida $4.41B AUM 90.53% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Barclays's HIMS Position: Q2 2026 in Review

Barclays increased its Hims & Hers Health (HIMS) stake by 35% in Q2 2026, buying an estimated $5.95M and bringing the position to 861,006 shares worth $29.9M. The position accounts for 0.01% of the portfolio, ranked #933.

Barclays first reported a position in HIMS in Q1 2022 and has held it in 18 quarters since. The position peaked at $37.4M in Q3 2025. 506 funds tracked by Wall St. Rank hold HIMS as of Q2 2026.

  • Barclays held 861,006 shares of Hims & Hers Health worth $29.9M as of Q2 2026.
  • Barclays bought 221,634 Hims & Hers Health shares in Q2 2026, an estimated $5.95M.
  • Hims & Hers Health made up 0.01% of Barclays's portfolio in Q2 2026, its #933 holding.
  • Barclays first reported a position in Hims & Hers Health in Q1 2022 and has held it in 18 quarters since.
  • Barclays's Hims & Hers Health position peaked at $37.4M in Q3 2025.
  • 506 funds tracked by Wall St. Rank held Hims & Hers Health as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.